The Myth of Prometheus in Metastatic Meningioma to the Liver: from Craniotomy to Hepatectomy
Overview
Cell Biology
Reproductive Medicine
Authors
Affiliations
Metastases from intracranial meningiomas are rare, and among them, meningiomas with hepatic dissemination are extremely rare. Therefore, there are currently no guidelines for staging and treatment of metastatic disease in meningioma, a disease that is a challenge for both the clinician and the pathologist. Our literature review revealed 24 cases of liver metastases originating from intracranial meningiomas. We used them to analyze the pathological patterns of dissemination and to assess the different management strategies available, the most efficient and beneficial being surgery and chemotherapy, especially in the case of meningiomas with hepatic and∕or systemic dissemination.
Borni M, Kammoun B, Taallah M, Mzid Y, Boudawara O, Boudawara M Ann Med Surg (Lond). 2024; 86(9):5631-5638.
PMID: 39239057 PMC: 11374259. DOI: 10.1097/MS9.0000000000002460.
Predictor factors for recurrence in atypical meningiomas.
Cucu A, Costea C, Turliuc S, Blaj L, Prutianu I, Dumitrescu G Rom J Morphol Embryol. 2023; 64(3):333-342.
PMID: 37867351 PMC: 10720934. DOI: 10.47162/RJME.64.3.05.
Feltracco H, Matar A, Smith S, Blair C, Sarmiento J J Surg Case Rep. 2023; 2023(5):rjad238.
PMID: 37153828 PMC: 10156433. DOI: 10.1093/jscr/rjad238.
Zhou Q, Han Y, Chen J Biomed Res Int. 2022; 2022:4861043.
PMID: 35898678 PMC: 9314166. DOI: 10.1155/2022/4861043.